TMPRSS2-ERG Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated With Abiraterone Acetate
Top Cited Papers
- 14 July 2011
- journal article
- Published by Elsevier in European Urology
- Vol. 60 (5), 897-904
- https://doi.org/10.1016/j.eururo.2011.07.011
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Abiraterone and Increased Survival in Metastatic Prostate CancerNew England Journal of Medicine, 2011
- Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate CancerCancer Cell, 2011
- The genomic complexity of primary human prostate cancerNature, 2011
- TMPRSS2–ERG gene fusion is associated with low Gleason scores and not with high-grade morphological featuresLaboratory Investigation, 2010
- Integrative Genomic Profiling of Human Prostate CancerCancer Cell, 2010
- An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer ProgressionCancer Cell, 2010
- Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesisNature Genetics, 2009
- Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancerNature Medicine, 2009
- ETS rearrangements and prostate cancer initiationNature, 2009
- Detection of Mutations inEGFRin Circulating Lung-Cancer CellsNew England Journal of Medicine, 2008